Literature DB >> 21567894

Liver transplantation in patients with alcoholic liver disease.

Michael R Lucey1.   

Abstract

Although alcoholic liver disease (ALD) is one of the most common indications for liver transplantation (LT), there are still unresolved controversies about the goals of treatment, the referral, evaluation, and selection of patients with ALD for LT, and their care after LT. It is uncertain whether there is a large unmet need for LT among patients with ALD because of the unmeasured effects of recent drinking, relapse, and recovery with abstinence in this population. A careful assessment of the extrahepatic effects of alcohol-related end-organ damage is needed for ALD patients who are referred for an LT evaluation. Although there clearly is a relationship between the length of sobriety and future abstinence, the present methods for predicting future drinking are inexact. The survival of ALD patients after LT is as good as the survival of non-ALD patients, although patients with coincident ALD and hepatitis C virus have higher mortality and morbidity rates. After LT, ALD patients have an increased risk of developing malignancies and cardiovascular disease. These risks appear to be linked to cigarette smoking. Covert drinking occurs both before and after transplantation, and approximately 20% of patients return to harmful drinking after LT. Harmful drinking after LT (instead of slips) causes liver damage and reduces survival. Better therapies for controlling addictions to alcohol and nicotine are needed for ALD patients both before and after LT.
Copyright © 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2011        PMID: 21567894     DOI: 10.1002/lt.22330

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  23 in total

Review 1.  Addiction specialist's role in liver transplantation procedures for alcoholic liver disease.

Authors:  Geert Dom; Hendrik Peuskens
Journal:  World J Hepatol       Date:  2015-08-18

2.  Patients with Alcoholic Liver Disease Have Worse Functional Status at Time of Liver Transplant Registration and Greater Waitlist and Post-transplant Mortality Which Is Compounded by Older Age.

Authors:  Patrick McCabe; Artin Galoosian; Robert J Wong
Journal:  Dig Dis Sci       Date:  2019-10-22       Impact factor: 3.199

Review 3.  Alcoholic hepatitis: current management.

Authors:  Erin K J Spengler; Jeffrey Dunkelberg; Ron Schey
Journal:  Dig Dis Sci       Date:  2014-05-06       Impact factor: 3.199

Review 4.  Ethical and allocation issues in liver transplant candidates with alcohol related liver disease.

Authors:  Mai Sedki; Aijaz Ahmed; Aparna Goel
Journal:  Transl Gastroenterol Hepatol       Date:  2022-07-25

Review 5.  [Psychiatric assessment of alcoholic patients on a waiting list for liver transplantation: which prognostic criteria are empirically proven?].

Authors:  M Soyka; F Stickel
Journal:  Nervenarzt       Date:  2013-09       Impact factor: 1.214

Review 6.  Candidates for liver transplantation with alcoholic liver disease: Psychosocial aspects.

Authors:  Diogo Telles-Correia; Inês Mega
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

Review 7.  Liver transplant-psychiatric and psychosocial aspects.

Authors:  Sandeep Grover; Siddharth Sarkar
Journal:  J Clin Exp Hepatol       Date:  2012-12-16

Review 8.  Challenges in transplantation for alcoholic liver disease.

Authors:  Gabriela A Berlakovich
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

9.  Nutritional status of patients with alcoholic cirrhosis undergoing liver transplantation: time trends and impact on survival.

Authors:  Ashwani K Singal; Patrick S Kamath; Nickie Francisco Ziller; Sara DiCecco; M Shoreibah; Walter Kremers; Michael R Charlton; Julie K Heimbach; Kymberly D Watt; Vijay H Shah
Journal:  Transpl Int       Date:  2013-06-11       Impact factor: 3.782

Review 10.  [Management of severe alcoholic hepatitis].

Authors:  Verena Wieser; Herbert Tilg
Journal:  Wien Med Wochenschr       Date:  2013-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.